SEC Company Response from Adagio Medical Holdings, (ADGM) — Dec 10, 2025
Adagio Medical Holdings, Inc.
Date: Dec. 10, 2025 · CIK: 0002006986 · Accession: 0001104659-25-119990
AI Filing Summary & Sentiment
File numbers found in text: 333-291741
Show Raw Text
CORRESP 1 filename1.htm A dagio Medical Holdings , I NC. 26051 Merit Circle, Suite 102 Laguna Hills, CA 92653 December 10, 2025 Via EDGAR U.S. Securities and Exchange Commission Division of Corporation Finance 100 F Street, N.E. Washington, D.C. 20549 Re: A dagio Medical Holdings, Inc. Registration Statement on Form S-3 (File No. 333-291741) Request for Acceleration of Effective Date Ladies and Gentlemen: In accordance with Rule 461 under the Securities Act of 1933, as amended, the undersigned registrant (the " Registrant ") hereby requests that the Securities and Exchange Commission (the " Commission ") take appropriate action to cause the above-referenced Registration Statement on Form S-3 (File No. 333-291741) (the " Registration Statement ") to become effective on December 12, 2025, at 4:00 p.m. Eastern Time, or as soon thereafter as is practicable, or at such other time as the Registrant or its legal counsel, Cooley LLP, may request by telephone to the staff of the Commission. The Registrant hereby authorizes each of Eric Blanchard and Paul Alexander of Cooley LLP to make such a request on its behalf. Once the Registration Statement has been declared effective, please confirm that event with Eric Blanchard of Cooley LLP, counsel to the Registrant, at (617) 937-2445 or eblanchard@cooley.com, or in his absence, Paul Alexander, at (202) 776-2118 or palexander@cooley.com. [Signature page follows] Very truly yours, Adagio Medical Holdings, Inc. By: /s/ Deborah Kaster Deborah Kaster Chief Financial Officer and Chief Business Officer cc: Todd Usen, Adagio Medical Holdings, Inc. Eric Blanchard, Cooley LLP Paul Alexander, Cooley LLP Signature Page to Company Acceleration Request – S-3